about
ASYMMETRIC CELL DIVISION: IMPLICATIONS FOR GLIOMA DEVELOPMENT AND TREATMENT.Evaluation of RANO response criteria compared to clinician evaluation in WHO grade III anaplastic astrocytoma: implications for clinical trial reporting and patterns of failure.Comparative transcriptomics reveals similarities and differences between astrocytoma grades.Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysis.Intramedullary spinal glioblastoma metastasis from anaplastic astrocytoma of cerebellum: A case report and review of the literature.First Experience of Intraoperative Radiation Therapy in Cerebral High Grade Glioma in Iran: A Report of Three Cases and Literature ReviewCPEB4 interacts with Vimentin and involves in progressive features and poor prognosis of patients with astrocytic tumors.Improved survival for elderly married glioblastoma patients : Better treatment delivery, less toxicity, and fewer disease complications.Identifying the association between contrast enhancement pattern, surgical resection, and prognosis in anaplastic glioma patients.Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the 'integrated' diagnosis approach.Anaplastic astrocytomas: survival and prognostic factors in a surgical series.Big Data Research in Neurosurgery: A Critical Look at this Popular New Study Design.Stereotactic brachytherapy using iodine 125 seeds for the treatment of primary and recurrent anaplastic glioma WHO° III.MicroRNA miR-1249 downregulates adenomatous polyposis coli 2 expression and promotes glioma cells proliferation.A radiomic signature as a non-invasive predictor of progression-free survival in patients with lower-grade gliomas
P2860
Q34723950-A8FA92DB-C649-4EE2-B640-52E475166F8CQ35214747-7DECBCD9-F834-47C0-A2AB-4423C39494A1Q35870174-9AF8B617-3292-40E2-B9A9-5D083373E4D4Q37250446-93E3FE8B-B41E-4B1B-B4B1-ED3E62F276CDQ38591366-6D7EF11F-F805-493F-AC6B-8FBF7BE84E97Q38658258-15D1BAB4-EED4-428A-8928-043DC7239AF6Q38945218-D00F1A0A-BDC9-4B3B-9E44-5E17B9D74509Q39389798-98A6A02D-8E71-4689-9E5F-D1AB6223E5F1Q40960183-D23AD5E9-1F80-4CF3-8AB2-8C45AB4926E1Q40993120-9EF6A80D-BCFC-4973-BD95-A13D09F01E54Q44354958-6AB9EA8C-728E-47F2-BA6E-298E0980D1B7Q47253349-B5B45274-B8D4-4D7D-BA76-7AE12EAC1FFDQ51765108-6C8F8384-7934-4771-89B4-A4F7775B3042Q54975281-449A0DC7-1015-47AB-BB33-F87FD2A9F6F9Q58557979-9597E0AD-348A-439D-BE0A-2F8CDD39DADB
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Survival and prognostic factors of anaplastic gliomas.
@ast
Survival and prognostic factors of anaplastic gliomas.
@en
Survival and prognostic factors of anaplastic gliomas.
@nl
type
label
Survival and prognostic factors of anaplastic gliomas.
@ast
Survival and prognostic factors of anaplastic gliomas.
@en
Survival and prognostic factors of anaplastic gliomas.
@nl
prefLabel
Survival and prognostic factors of anaplastic gliomas.
@ast
Survival and prognostic factors of anaplastic gliomas.
@en
Survival and prognostic factors of anaplastic gliomas.
@nl
P2093
P1433
P1476
Survival and prognostic factors of anaplastic gliomas.
@en
P2093
Chirag G Patil
Debraj Mukherjee
J Manuel Sarmiento
Keith L Black
Kurtis Birch
Miriam Nuño
P304
458-65; quiz 465
P356
10.1227/01.NEU.0000431477.02408.5E
P407
P577
2013-09-01T00:00:00Z